- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Future of imaging science depends on risk takers
Radiologists need to become great risk takers and follow clinical science's move toward systems biology or become irrelevant, according to Dr. Elias Zerhouni, director of the National Institutes of Health.
Radiologists need to become great risk takers and follow clinical science's move toward systems biology or become irrelevant, according to Dr. Elias Zerhouni, director of the National Institutes of Health.
Imagers need to replace the current imaging approach to understand complex disease mechanisms, such as inflammation or apoptosis, rather than simply specific conditions, like arthritis or cancer. That means moving down the angstrom scale to resolve complex macromolecular structures, Zerhouni said.
Radiologists should develop biomarkers to assist in the study of treatments for long-term chronic diseases and get involved in image-guided intervention and microsampling for disease characterization, he said.
Zerhouni spoke during a session on the future of biomedical imaging and imaging research at the European Congress of Radiology. The NIH will invest about $1 billion in 2007 in projects with non-U.S. partners.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
